Infectious complications of prostate biopsy: Winning battles but not war

Basit Öğe Kaydı
dc.authorid0000-0001-6311-5428
dc.contributor.authorDerin, Okan
dc.contributor.authorFonseca, Limirio
dc.contributor.authorSalas, Rafael
dc.contributor.authorRoberts, Matthew
dc.date.accessioned2020-12-01T07:02:06Z
dc.date.available2020-12-01T07:02:06Z
dc.date.issued2020
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı
dc.description.abstractBackground Prostate biopsy is a standard tool for diagnosing prostate cancer, with more than 4 million procedures performed worldwide each year. Infectious complications and economic burden are reportedly rising with continued use of trans-rectal ultrasound-guided biopsy, despite the transperineal approach being associated with less infectious complications. Objective and methods In this review, the contemporary literature on pathophysiology, epidemiology, risk factors, causative organisms and emerging approaches for prevention of infectious complications are outlined. Results Management of infectious complications after TRUSB has caused significant financial burden on health systems. The most frequent causative agents of infectious complications after prostate biopsy are Gram-negative bacilli are particularly concerning in the era of antibiotic resistance. Increasing resistance to fluoroquinolones and beta-lactam antibiotics has complicated traditional preventive measures. Patient- and procedure-related risk factors, reported by individual studies, can contribute to infectious complications after prostate biopsy. Conclusions Recent literature shows that the transrectal ultrasound-guided prostate biopsy results in higher infectious complication rate than the transperineal prostate biopsy. NAATs, recently introduced technique to detect FQr may detect all antibiotic-resistant rectal microbiota members-included MDRs-although the technique still has limitations and economical burdens. Transient solutions are escalating antibiotic prophylaxis and widening the indications for TPB.
dc.identifier.citationDerin, O., Fonseca, L., Salas, R. ve Roberts, M. (2020). Infectious complications of prostate biopsy: Winning battles but not war. World Journal of Urology, 38(11), 2743-2753. https://dx.doi.org/10.1007/s00345-020-03112-3
dc.identifier.doi10.1007/s00345-020-03112-3
dc.identifier.endpage2753
dc.identifier.issn0724-4983
dc.identifier.issn1433-8726
dc.identifier.issue11
dc.identifier.scopusqualityQ1
dc.identifier.startpage2743
dc.identifier.urihttps://dx.doi.org/10.1007/s00345-020-03112-3
dc.identifier.urihttps://hdl.handle.net/20.500.12511/6063
dc.identifier.volume38
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofWorld Journal of Urologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectProstate Biopsy
dc.subjectInfectious Complications
dc.subjectAntimicrobial Resistance
dc.subjectPreventive Measures
dc.titleInfectious complications of prostate biopsy: Winning battles but not war
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Derin, Okan-2020.pdf
Boyut:
1.39 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu